Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
DSGN — Design Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q4 2023 Earnings Call Summary

MAR 19, 2024
REVENUE
$0
EPS
-$0.21 +25.0%
FREE CASH FLOW
-$12.8M +12.1%

No summary has been written for this call yet.